THE MORNING SHOW
Dr. Anthony Kleinsmith
Building Immunity with Colostrum
April 17, 2012
You hear Patrick regularly singing the praises of colostrum, one of his daily superfoods. So what exactly is this magical product? And why would humans consume it? Doesn’t it cause cancer like one of our other guests hasinsisted? How does it strengthen the immune system? Dr. Anthony Kleinsmith answers these questions and many more.
Dr. Anthony Kleinsmith, is the President and founder of Immune Tree, Inc. He received dual degrees from Chatworth College; his Ph.D. is in Nutritional Science and he is a board certified Doctor of Naturopathy.
Dr. Kleinsmith has 18 years of experience in the research of nutritional health. He has been formulating for Immune Tree as well as other companies around the world for the past 16 years. He has formulated and been involved with research for both human and animal health; and his product development has reached into Asia, Africa, Europe, North and South America. His specialty and focus have been on Anti-Aging, Immune Enhancement/Regulation, and Weight Loss. His work with recombinant forms of growth hormones lead him to solidify research on natural forms on the IGF-1/GH Super Family found in abundance in his colostrum.
During the last two decades in the nutritional industry, Dr. Kleinsmith has helped establish several unique contract manufacturing facilities. These facilities have focused on the ability to maintain the integrity of natural substances without the use of additives or fillers.
Dr. Kleinsmith has authored numerous articles for various health magazines, made TV appearances, and is a regular on several National radio shows. He has also toured the world as a public speaker.
Dr. Anthony Kleinsmith is considered one of the world’s leading authorities on colostrum. Test after test from institutions like Cornell University, laboratories like MVTL, and doctors such as Dr. Michael Loper, M.D. have confirmed the superior quality of his product line.
dr anthony kleinsmith and the magic of colsotrum, april 17, 2012